FIELD: pharmacology.
SUBSTANCE: invention relates to new 9-benzyl-2-biphenylimidazo[1,2-a]benzimidazole (I) and pharmaceutically acceptable salts thereof.
EFFECT: imidazobenzimidazole derivatives having the property of destroyers of transversal cross-links of glycosylated proteins.
3 cl, 2 dwg, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
HALIDES OF 1-(4-TERT-BUTYLPHENYL)-2-{3-[2-(4-FLUORO-PHENOXY)ETHYL]-2-METHYL-3H-BENZIMIDAZOLE-1-YL}ETHANONE WITH PROPERTY OF RUPTURE CROSS-LINKERS OF GLYCATED PROTEINS | 2016 |
|
RU2635112C1 |
9-SUBSTITUTED-2-BIPHENYLIMIDAZO[1,2-A]BENZIMIDAZOLES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, HAVING ANTIOXIDANT AND ANTIRADICAL PROPERTIES | 2017 |
|
RU2649979C1 |
1,3-BIS(4-METHOXYBENZOYL)PYRIMIDINE-2,4(1H,3H)-DIONE WITH ACTIVITY ASSOCIATED WITH GLYCATED PROTEINS CROSS LINKAGE BREAKING | 2017 |
|
RU2643520C1 |
HYDROBROMID 4'-(2,3-DIGIDRO-9H-IMIDAZO[1,2-A]BENZIMIDAZOLE-9-YL-METHYL)BIPHENYL-2-CARBONITRIL EXHIBITING THE PROPERTIES OF THE ACTIVATOR OF AMP-ACTIVATED PROTEINKINASE (AMPA) | 2017 |
|
RU2650877C1 |
1-(3-MORPHOLINOPROPYL)-2-PHENYLIMIDAZO[1,2-a]-BENZIMIDAZOLE DIHYDROCHLORIDE, HAVING PURINE P2Y-RECEPTOR ANTAGONIST PROPERTIES, ANTIAGGREGANT AND ANTITHROMBOTIC ACTIVITY | 2008 |
|
RU2391345C2 |
1-SUBSTITUTED-3-{[2-(3,5-DI-TRET-4-HYDROXYPHENYL)-2-OXOETHYL]}-2AMINOBENZIMIDAZOLIUM BROMIDES WITH ANTIPLATELET AND ANTIOXIDANT PROPERTIES | 2016 |
|
RU2623439C1 |
AGENT POSSESSING CARDIO-, NEPHRO-, ENDOTHELIAL-, MICROANGIO-, MACROANGIO- AND ENCEPHALOPROTECTIVE PROPERTIES | 2018 |
|
RU2700791C1 |
METHOD OF PRODUCING 1(11)H-2,3,4,5-TETRAHYDRO[1,3]DIAZEPINO[1,2-a]BENZIMIDAZOLE | 2023 |
|
RU2814769C1 |
11-(4-TERT-BUTYLBENZYL)-2,3,4,5-TETRAHYDRO[1,3]DYAZEPINO[1,2-A]BENZIMIDAZOLE HYDROBROMIDE WITH ANXIOLYTIC AND ANTICONVULSANT ACTIVITY | 2017 |
|
RU2662242C1 |
3-GUANIDINOAZOLO[1,2,4,5]TETRAZINES HAVING ANTIGLYCATING ACTIVITY AND A PROCESS FOR THEIR PREPARATION | 2017 |
|
RU2668971C1 |
Authors
Dates
2017-08-11—Published
2016-10-28—Filed